Last quarter (Q ), MyMD Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q, MyMD Pharmaceuticals's net income was $2.88M. See MyMD Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20
Total Revenue	-	-	-	$ 0.00
Cost of Revenue	-	-	$ 15.04M	$ 0.00
Gross Profit	-	-	$ -15.04M	$ 0.00
Operating Expense	$ 12.37M	$ 15.28M	$ 13.77M	$ 8.30M
Operating Income	$ -12.37M	$ -15.28M	$ -28.81M	$ -8.30M
Net Non Operating Interest Income Expense	$ -117.61K	-	$ -1.09M	$ -1.19M
Other Income Expense	$ -6.56M	$ -76.54K	$ -5.71K	-
Pretax Income	$ -5.38M	$ -15.20M	$ -29.89M	$ -9.49M
Tax Provision	-	$ -5.91M	-	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-
Net Income Common Stockholders	$ -5.50M	$ -15.21M	$ -29.89M	$ -9.49M
Basic EPS	$ -0.39	$ -0.39	$ -0.85	$ -0.26
Diluted EPS	$ -0.09	$ -0.39	$ -0.85	$ -0.26
Basic Average Shares	$ 163.91M	$ 38.83M	$ 35.02M	$ 37.14M
Diluted Average Shares	$ 125.09M	$ 38.83M	$ 35.02M	$ 37.14M
Dividend Per Share	-	-	-	-
Total Operating Income As Reported	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-
Rent Expense Supplemental	-	-	-	-
Total Expenses	$ 12.37M	$ 15.28M	$ 28.81M	$ 8.30M
Net Income From Continuing And Discontinued Operation	$ -5.38M	$ -15.20M	$ -29.89M	$ -9.49M
Normalized Income	$ -98.48K	-	-	$ -9.49M
Interest Expense	-	-	-	$ 1.19M
EBIT	$ -5.39M	$ -15.20M	$ -29.89M	$ -8.30M
EBITDA	$ -5.39M	$ -15.20M	$ -29.28M	$ -8.28M

Currency in USD

MyMD Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing